These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 12630807

  • 1. Specificity of porcine calcitonin receptor and calcitonin receptor-like receptor in the presence of receptor-activity-modifying proteins.
    Kikumoto K, Katafuchi T, Minamino N.
    Hypertens Res; 2003 Feb; 26 Suppl():S15-23. PubMed ID: 12630807
    [Abstract] [Full Text] [Related]

  • 2. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
    Oliver KR, Kane SA, Salvatore CA, Mallee JJ, Kinsey AM, Koblan KS, Keyvan-Fouladi N, Heavens RP, Wainwright A, Jacobson M, Dickerson IM, Hill RG.
    Eur J Neurosci; 2001 Aug; 14(4):618-28. PubMed ID: 11556887
    [Abstract] [Full Text] [Related]

  • 3. Receptor activity modifying proteins interaction with human and porcine calcitonin receptor-like receptor (CRLR) in HEK-293 cells.
    Aiyar N, Disa J, Pullen M, Nambi P.
    Mol Cell Biochem; 2001 Aug; 224(1-2):123-33. PubMed ID: 11693189
    [Abstract] [Full Text] [Related]

  • 4. Coexpression of calcitonin receptor-like receptor and receptor activity-modifying protein 2 or 3 mediates the antimigratory effect of adrenomedullin.
    Fukai N, Shichiri M, Ozawa N, Matsushita M, Hirata Y.
    Endocrinology; 2003 Feb; 144(2):447-53. PubMed ID: 12538603
    [Abstract] [Full Text] [Related]

  • 5. CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.
    Hasbak P, Sams A, Schifter S, Longmore J, Edvinsson L.
    Br J Pharmacol; 2001 Aug; 133(8):1405-13. PubMed ID: 11498528
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Glycosylation of human CRLR at Asn123 is required for ligand binding and signaling.
    Kamitani S, Sakata T.
    Biochim Biophys Acta; 2001 May 28; 1539(1-2):131-9. PubMed ID: 11389975
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor.
    Fraser NJ, Wise A, Brown J, McLatchie LM, Main MJ, Foord SM.
    Mol Pharmacol; 1999 Jun 28; 55(6):1054-9. PubMed ID: 10347248
    [Abstract] [Full Text] [Related]

  • 12. Functional expression of heteromeric calcitonin gene-related peptide and adrenomedullin receptors in yeast.
    Miret JJ, Rakhilina L, Silverman L, Oehlen B.
    J Biol Chem; 2002 Mar 01; 277(9):6881-7. PubMed ID: 11733510
    [Abstract] [Full Text] [Related]

  • 13. Molecular cloning and pharmacological characterization of bovine calcitonin receptor-like receptor from bovine aortic endothelial cells.
    Aiyar N, Disa J, Ao Z, Xu D, Surya A, Pillarisetti K, Parameswaran N, Gupta SK, Douglas SA, Nambi P.
    Biochem Pharmacol; 2002 Jun 01; 63(11):1949-59. PubMed ID: 12093471
    [Abstract] [Full Text] [Related]

  • 14. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
    Thota C, Gangula PR, Dong YL, Yallampalli C.
    Biol Reprod; 2003 Oct 01; 69(4):1432-7. PubMed ID: 12801991
    [Abstract] [Full Text] [Related]

  • 15. Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure.
    Cueille C, Pidoux E, de Vernejoul MC, Ventura-Clapier R, Garel JM.
    Biochem Biophys Res Commun; 2002 Jun 07; 294(2):340-6. PubMed ID: 12051717
    [Abstract] [Full Text] [Related]

  • 16. Adrenomedullin and related peptides: receptors and accessory proteins.
    Muff R, Born W, Fischer JA.
    Peptides; 2001 Nov 07; 22(11):1765-72. PubMed ID: 11754962
    [Abstract] [Full Text] [Related]

  • 17. Production of cAMP by adrenomedullin in human oligodendroglial cell line KG1C: comparison with calcitonin gene-related peptide and amylin.
    Uezono Y, Nakamura E, Ueda Y, Shibuya I, Ueta Y, Yokoo H, Yanagita T, Toyohira Y, Kobayashi H, Yanagihara N, Wada A.
    Brain Res Mol Brain Res; 2001 Dec 16; 97(1):59-69. PubMed ID: 11744163
    [Abstract] [Full Text] [Related]

  • 18. Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins.
    Hilairet S, Foord SM, Marshall FH, Bouvier M.
    J Biol Chem; 2001 Aug 03; 276(31):29575-81. PubMed ID: 11387328
    [Abstract] [Full Text] [Related]

  • 19. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T, Christopoulos G, Bailey RJ, Christopoulos A, Sexton PM, Hay DL.
    Mol Pharmacol; 2008 Oct 03; 74(4):1059-71. PubMed ID: 18593822
    [Abstract] [Full Text] [Related]

  • 20. Mouse receptor-activity-modifying proteins 1, -2 and -3: amino acid sequence, expression and function.
    Husmann K, Sexton PM, Fischer JA, Born W.
    Mol Cell Endocrinol; 2000 Apr 25; 162(1-2):35-43. PubMed ID: 10854696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.